Jeff Yass’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-248,300
Closed -$978K – 13749
2026
Q2
$978K Buy
+248,300
New +$903K ﹤0.01% 8253
2026
Q1
– Sell
-13,000
Closed -$19.6K – 13381
2025
Q4
$19.6K Sell
13,000
-29,500
-69% -$70.1K ﹤0.01% 11966
2025
Q3
$110K Buy
+42,500
New +$124K ﹤0.01% 11504

Other funds holding ELDN

Jeff Yass's ELDN Position: Q3 2026 in Review

Jeff Yass reduced its Eledon Pharmaceuticals (ELDN) stake by 43% in Q3 2026, selling an estimated $363K and leaving 144,158 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #10507.

Jeff Yass first reported a position in ELDN in Q4 2014 and has held it in 20 quarters since. The position peaked at $5.38M in Q1 2025. 153 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Jeff Yass held 144,158 shares of Eledon Pharmaceuticals worth $365K as of Q3 2026.
  • Jeff Yass sold 108,074 Eledon Pharmaceuticals shares in Q3 2026, an estimated $363K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10507 holding.
  • Jeff Yass first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 20 quarters since.
  • Jeff Yass's Eledon Pharmaceuticals position peaked at $5.38M in Q1 2025.
  • 153 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.